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Bone morphogenetic protein 4 modulates c-Kit expression and
differentiation potential in murine embryonic aorta-gonad-
mesonephros haematopoiesis in vitro
Haematopoietic stem cells (HSCs) capable of long-term
multilineage reconstitution in myeloablated recipient mice
ﬁrst arise during embryogenesis and persist into adult life. The
differentiation pathways and cytokine requirements through
which haematopoietic progenitor cells achieve maturity in all
blood cell lineages have been studied extensively and are well
characterized. However, the processes by which the stem cells
and precursors that seed the adult multilineage blood system
are generated and maintained are less well understood. Stem
cell homeostasis depends on maintaining a balance between
self-renewal, proliferation, death and differentiation. Identiﬁ-
cation of the factors that regulate HSC emergence and
subsequent development will provide insight into how the
mammalian haematopoietic system is formed and how the
decision to self-renew or differentiate is controlled at the
molecular level.
During mammalian embryogenesis, the ﬁrst multipotent
HSCs are detected within a region of mesodermal tissue
containing the dorsal aorta, gonadal ridge and mesonephros,
the aorta-gonad-mesonephros (AGM) region, at between 8Æ5
and 11Æ5 day post coitum (dpc) in the mouse and 4–6 weeks
gestation in the human embryo (Godin et al, 1995; Med-
vinsky & Dzierzak, 1996; Godin et al, 1999; Tavian et al,
2001). Within this region, CD45
+ haematopoietic cells
aggregate in clusters associated with major vessel walls,
including the ventral wall of the dorsal aorta (Tavian et al,
1996). However, the precise origins of this speciﬁc popula-
tion of embryonic cells and the nature of the signals
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Summary
The transforming growth factor-b-related factor bone morphogenetic protein
4 (BMP4) is expressed in the human embryonic aorta-gonad-mesonephros
(AGM) coincident with the emergence of haematopoietic cells and inﬂuences
postnatal mammalian haematopoietic stem cells in vitro. To investigate the
role of BMP4 in mammalian embryonic haematopoiesis, cells were isolated
from murine AGM and two populations of CD34
+ cells with different levels
of c-Kit expression and multipotency were identiﬁed. CD34
+/c-Kit
high cells
express CD45 and are haematopoietic-restricted progenitors. In contrast,
CD34
+/c-Kit
low cells are Flk1+/CD45
neg and generate adherent colonies in ex
vivo culture that resemble haemangioblast colonies identiﬁed in other
systems. The addition of BMP4 to AGM cells resulted in expansion of the
CD34
+/c-Kit
low cell pool within 48 h, via a combination of down modulation
of the c-Kit receptor in CD34
+/c-Kit
high cells and proliferation. In long-term
culture, BMP4 increased the growth/survival of CD34
+/c-Kit
high
haematopoietic progenitors, effects that were blocked by BMP inhibitors.
CD34
+/c-Kit
high progenitors cultured with BMP4 also generated adherent
colonies typical of c-Kit
low cells. These results suggest that BMP4 regulates
c-Kit expression and differentiation potential in CD34
+ AGM cells and
supports a role for BMP signalling in the maintenance of multipotency
during embryonic haematopoiesis, providing an insight into stem cell
homeostasis within the mammalian haematopoietic niche.
Keywords: Bone morphogenetic protein, haematopoiesis, aorta-gonad-
mesonephros, c-Kit, haemangioblast.
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yet to be fully deﬁned.
Progenitors that display haemangioblast (haematopoietic
and endothelial) potential in vitro, similar to embryonic stem
(ES) cell lines, have been identiﬁed early in the development of
the gastrulating mouse embryo (Choi et al, 1998; Huber et al,
2004). The proximity of intraaortic HSCs to endothelial cells
lining the dorsal aorta, combined with the overlapping
expression proﬁles between the two populations, suggest that
HSCs and endothelial cells arise from a bipotential precursor,
the haemangioblast, located within or adjacent to the aortic
wall (Marshall & Thrasher, 2001). In support of this, CD34
+/
CD45
) endothelial cells isolated from 5-week human AGM
lack haematopoietic potential initially but produce blood cells
when cultured in the presence of stromal cells that support
multilineage haematopoiesis (Oberlin et al, 2002). Haemato-
poietic output from endothelial cells both quantitatively and
temporally reﬂects the degree of haematopoietic activity in vivo
and is restricted to blood-forming tissues.
A number of extrinsic factors have been reported to
inﬂuence haematopoiesis including members of the hedgehog,
Wnt, Notch and transforming growth factor-b (TGFb)/bone
morphogenetic protein (BMP) families (Fortunel et al, 2000;
Bhardwaj et al, 2001; Kumano et al, 2003; Reya et al, 2003;
Sadlon et al, 2004; Androutsellis-Theotokis et al, 2006; Neves
et al, 2006). BMPs have a broad spectrum of effects during
embryogenesis, ranging from induction of ventral mesoderm
to patterning a variety of tissues (Winnier et al, 1995; Hogan,
1996). During lower vertebrate (Xenopus) embryogenesis the
genetic programming of putative haemangioblasts is regulated
by bone morphogenetic protein 4 (BMP4) (Walmsley et al,
2002). BMPs also enhance self-renewal and increase the
haematopoietic potential of ES cells (Johansson & Wiles,
1995; Chadwick et al, 2003; Chambers & Smith, 2004).
Recently, BMP signalling has been implicated in adult murine
bone marrow homeostasis in the regulation of niche size and
stem cell numbers (Zhang et al, 2003). In vitro, while BMP4
maintains the proliferative potential of cord blood-derived
CD34
+ haematopoietic progenitors, TGFb regulates cell cycle
status and expression of the stem cell factor receptor c-Kit to
maintain a primitive, undifferentiated population (Sansilvestri
et al, 1995; Bhatia et al, 1999; Morita et al, 2003).
We have previously shown that BMP4 is expressed in
a distinctive pattern underlying the ventral wall of the dorsal
aorta associated with the appearance of intraaortic haemato-
poietic clusters in the AGM region of 5-week old human
embryos (Marshall et al, 2000). To investigate the role of
BMP4 at the onset of multipotent haematopoietic develop-
ment during mammalian embryogenesis, we have isolated cells
co-expressing CD34 and c-Kit from the AGM region of mid-
gestation murine embryos (9Æ5–11Æ5 dpc), at the time of
normal HSC emergence. This CD34
+/c-Kit+ population has
previously been shown to give rise to cells of all haematopoietic
lineages in vitro indicating that it contains multipotent HSCs
(Delassus et al, 1999). Coincident with the peak of AGM
haematopoietic activity in vivo, we have identiﬁed two
populations of CD34
+ AGM cells that differ in c-Kit expression
and differentiation potential. BMP4, speciﬁcally, modulates the
size and potential of these populations ex vivo, similar to the
effects of TGFb in the adult blood system. This effect can be
neutralized by inhibition of BMP signalling using antagonists.
These ﬁndings, together with the observed in vivo expression
pattern, support a role for BMP4 in the development and
regulation of early haematopoietic progenitors within the
mammalian embryonic AGM region.
Methods
AGM dissection and cell preparation
Timed matings of wild-type CD1 mice generated embryos at
embryonic day (9Æ5, 10Æ5 and 11Æ5). From each embryo, the
AGM region between the anterior limb bud and umbilical
vessels, containing the dorsal aorta, was dissected in phos-
phate-buffered saline (PBS). AGMs from single litters were
pooled and dissociated in cell dissociation buffer (Invitrogen
Ltd, Paisley, UK) for 15 min at 37 C followed by gentle
trituration through 23 and 25 G needles. Single cells were
ﬁltered through a 70 lm cell strainer and washed with Hank’s
balanced salt solution (HBSS) supplemented with 1% bovine
serum albumin (BSA).
Flow cytometry and ﬂuorescence-activated cell sorting
Dissociated AGM cells were incubated with ﬂuorescence-
conjugated antibodies (BD Biosciences Pharmingen, San
Diego, CA, USA) for 30 min at 4 C. Antibodies used for ﬂow
cytometry were: rat anti-mouse CD34 (RAM34)-ﬂuorescein
isothiocyanate (FITC) or phycoerythrin (PE); Flk1 (Ava-
s12a1)-PE; CD117 (c-Kit/2B8)-allophycocyanin (APC) and
CD45(30-F11)-peridinin chlorophyll (PerCP). Antibodies for
ﬂuorescence-activated cell sorting (FACS) were: rat anti-mouse
CD34 (RAM34)-FITC and CD117 (c-Kit/2B8)-PE. Cells were
washed with HBSS/1% BSA and either sorted using an EPICS
Altra ﬂuorescent activated cell sorter with Autoclone  sorting
option (Beckman Coulter, High Wycombe, UK) or analysed
using a CyAn ADP ﬂow cytometer (Dakocytomation, Cam-
bridge, UK).
Cell culture
Total AGM cells were plated into 6-well tissue culture plates.
FACS-sorted cells were dispensed directly into 96-well tissue
culture plates at 50 cells/well onto adherent irradiated S17
stromal cells (plated at 2000 cells/well 24 h previously). Cells
were cultured in serum-free CellGro stem cell growth medium
(CellGenix, Freiburg, Germany) supplemented with 10
)4mol/l
2-mercaptoethanol. Additional factors were added as appro-
priate on day 1, including recombinant human BMP4 (10 ng/
ml), murine BMPR-IB/ALK-6/Fc chimaera (200 ng/ml) and
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Minneapolis, MN, USA), 25 ng/ml stem cell factor (SCF)
(Peprotech Inc, Rocky Hill, NJ, USA). Human BMP4 has been
shown to be biochemically active in the murine carcinoma-
derived chondrogenic cell line ATCD5. Cells were incubated
for 2, 10 or 20 d at 37 C, 5% CO2. To avoid disturbing the
small number of cells plated, the medium was not changed
during the 2- and 10-d culture periods. For 20-d cultures,
medium was changed at day 10 and BMP4 re-added. Statistical
analyses were performed using the Wilcoxon signed ranks test
(same embryonic age) and the Kruskal–Wallis test (different
embryonic ages). For ﬂow cytometric analysis, cells were
labelled with the ﬂuorescent dye tetramethyl-6-carboxyrhod-
amine [TAMRA; 1 ng/ml in minimum essential medium
(MEM)/PBS] at 37 C for 15 min.
Colony-forming unit assay
Primary colonies of AGM-derived cells were trypsinised,
washed and resuspended to a single-cell suspension in Iscove’s
Modiﬁed Dulbeccos medium (Invitrogen Ltd). Disrupted
colonies were plated into 35 mm bacterial Petri dishes in
Methocult GF complete methylcellulose medium containing
recombinant cytokines [erythropoietin, interleukin (IL)-3,
IL-6, stem cell factor (SCF)] suitable for colony assays of
murine cells (Stemcell Technologies Inc., Vancouver, BC,
Canada). Colonies were scored by morphology after 20 d.
Microscopy
Colonies/cells were analysed using a Nikon Eclipse TS100
inverted microscope (Nikon Corporation, Tokyo, Japan) with
a2 0 ·/0Æ40 objective for bright ﬁeld. Images were captured with
a Nikon Coolpix 4500 digital camera and processed using
Adobe Photoshop 5Æ5 (Adobe systems, San Jose, CA, USA).
Results
Mid-gestation murine CD34
+ AGM cells generate
morphologically different colonies depending on
level of c-Kit expression
Flow cytometric analysis of cells isolated from mid-gestation
murine embryos (pooled 10Æ5 dpc littermates) suggested that
the AGM contained two subpopulations of CD34
+ cells that
differentially expressed c-Kit (Fig 1A). These two subpopula-
tions were also analysed for expression of the vascular
endothelial growth factor receptor Flk1 and the pan-leucocyte
marker CD45. The majority of CD34
+/c-Kit
high cells were
Flk1
neg/CD45
+ and probably correspond to cells within the
intraaortic haematopoietic clusters. In contrast, CD34
+/
c-Kit
low cells were mainly Flk1+/CD45
neg.
To assess haematopoietic potential, FACS-sorted AGM cells
were plated in methylcellulose medium containing a cocktail of
cytokines to identify colony-forming cells. All colony-forming
unit (CFU) activity was contained within the CD34
+/c-Kit+
positive population but the potential of colony-forming cells
differed depending on the level of c-Kit expression (Fig 1B).
Haematopoietic granulocyte-macrophage CFU (CFU-GM)
activity was restricted to the CD34
+/c-Kit
high cell fraction with
a frequency of 2000 CFU per 1 · 10
6 CD34
+/c-Kit
high cells. In
contrast, CD34
+/c-Kit
low cells generated exclusively adherent
colonies containing a combination of three morphologically
distinct cell types: phase-dim spindle-shaped cells; large round
cells and clusters of small, round phase-bright cells. Cells that
did not express either marker (CD34
)/c-Kit
neg) failed to
generate any colonies. Similarly, no CFU activity was detect-
able in the single-positive cell fractions (CD34
+/c-Kit
neg,
CD34
)/c-Kit+).
We investigated the effect of BMP4 on c-Kit expression
levels in AGM-derived murine cells. Unsorted AGM cells
(10Æ5 dpc) were cultured on a low-density monolayer of
irradiated S17 stromal cells in serum-free medium alone or
medium supplemented with recombinant BMP4 (10 ng/ml).
Cells were collected at day 2 and analysed by ﬂow cytometry
for CD34 and c-Kit expression compared to the starting
population. In a representative experiment, CD34
+/c-Kit
high
and CD34
+/c-Kit
low cells initially comprised around 0Æ1% and
1% of total AGM cells respectively (Fig 1C). After 2 d in
serum-free culture ()BMP4) there was a minimal increase in
CD34
+/c-Kit+ cells although the ratio of CD34
+/c-Kit
high and
CD34
+/c-Kit
low cells was similar to day 0. In contrast, addition
of BMP4 (+BMP4) resulted in a greater expansion in the
CD34
+/c-Kit
low population (from 3Æ2% to 11Æ6%) compared to
day 0 and serum-free controls.
BMP4 increases the growth/survival of AGM-derived
CD34
+/c-kit
high cells in vitro
Modulation of c-Kit expression may be one mechanism by
which the balance between blood cell precursors and progen-
itors is maintained during AGM haematopoiesis. We therefore
investigated the longer term effects of BMP4 on AGM-derived
CD34
+/c-Kit
high cells isolated by FACS from embryos aged
between 9Æ5 and 11Æ5 dpc and cultured as above on irradiated
S17 stromal cells in serum-free conditions with or without
BMP4 (10 ng/ml) for 10 d. At the end of the culture period,
the number of AGM-derived colonies generated under each
condition (plating efﬁciency) was scored.
The plating efﬁciency of CD34
+/c-Kit
high cells isolated from
9Æ5 dpc and 11Æ5 dpc AGM was generally low (<10 CFU/10
4
cells plated) compared with 10Æ5 dpc (up to 30 CFU/10
4 cells),
suggesting that ex vivo survival or growth capacity of CD34
+/c-
Kit
high cells differed with embryonic age. Addition of BMP4 to
9Æ5o r1 1 Æ5 dpc CD34
+/c-kit
high cells resulted in only minimal
increases in plating efﬁciency compared to medium only
controls (Fig 2A). In contrast, the number of colonies
generated from BMP4-treated 10Æ5 dpc CD34
+/c-Kit
high cells
increased signiﬁcantly (P <0 Æ001) and reproducibly with
a greater than twofold increase in 14 out of 19 independent
BMP4 in Murine Embryonic Haematopoiesis
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(Fig 2B). Addition of c-Kit ligand (25 ng/ml), either alone or
in combination with BMP4, had no observable effect on
colony number, size or morphology.
The effects of BMP4 are neutralized by BMP-antagonists
To test whether the observed increase in colony formation
from 10Æ5 dpc AGM-derived CD34
+/c-kit
high cells was
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Fig 1. Mid gestation murine CD34
+ aorta-gonad-mesonephros (AGM) cells contain subpopulations that differ in levels of c-Kit expression, dif-
ferentiation potential and response to bone morphogenetic protein 4 (BMP4). (A) AGM cells (10Æ5 dpc) were analysed by ﬂow cytometry (CyAn ADP
Flow Cytometer) for expression of CD34, c-Kit, Flk1 and CD45 to identify subpopulations. Representative results are shown. CD34
+/c-Kit+ cells can
be subdivided into c-Kit
high and c-Kit
low fractions (areas a & b). Differential expression proﬁles of (a) CD34
+/c-Kit
high and (b) CD34
+/c-Kit
low
fractions for expression of Flk1 and CD45. Dotted arrows indicate expansion of gated areas a and b as indicated. To maintain accuracy, analysis of the
c-Kit
low and c-Kit
high cell fractions could only be performed on small numbers of cells per experiment (pooled littermates) however the distribution of
expression was consistent between experiments. (B) CD34
+/c-Kit
high cells generate haematopoietic colonies of typical CFU-GM morphology. CD34
+/
c-Kit
low cells generate exclusively adherent colonies containing multiple cell types: phase-dim spindle-shaped cells (lower arrowhead), large round
cells (arrow) and phase-bright small, round cells (upper arrowhead). (C) Unsorted (total) AGM cells were cultured in serum-free conditions )/+
recombinant BMP4 (10 ng/ml) for 2 d and changes in the CD34
+/c-Kit
high/low subpopulations analysed by ﬂow cytometry (CyAn ADP cytometer).
Without added BMP4 ()BMP4), the percentage of CD34
+/c-Kit
high/low cells increases slightly in culture from day 0 but the ratio of CD34
+/c-Kit
high to
CD34
+/c-Kit
low remains relatively constant. With the addition of BMP4, there is a considerable increase in the CD34
+/c-Kit
low population compared
to day 0 and to cells cultured without added BMP4. Irradiated S17 feeder cells appear to express CD34, accounting for the apparent increase in
CD34
+/c-Kit
neg in cultured cells, but are c-Kit
neg.
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and recombinant soluble BMP type I-receptor (BMPR-IB)
were added in combination with BMP4 to block BMP
signalling in culture. Noggin is one of a number of antagonistic
agents that regulate BMP bioactivity during embryonic devel-
opment by sequestering BMP molecules in the extracellular
space. Recombinant BMPR acts in a similar way in vitro,
binding BMP4 with high afﬁnity in solution. After 10 d in
culture with BMPR or noggin (200 ng/ml) the number of
colonies generated fell to control levels or less (Fig 2C and D).
The inhibitors were not toxic at the concentrations used and
the number, size and morphology of colonies were comparable
to untreated controls ()BMP4). In one experiment (Fig 2D,
experiment 2), although BMP4 alone had no signiﬁcant effect,
addition of noggin reduced the number of colonies formed.
However, this result was not typical and in other experiments
noggin had a similar effect to BMP-R.
The ability of AGM-derived CD34
+/c-kit
high cells to survive
and/or proliferate in vitro, therefore, increased in the presence
of exogenous BMP4. This effect was blocked by BMP
inhibitors and, at this developmental stage, did not require
the addition of c-Kit ligand.
BMP4-treated CD34
+/c-Kit
high AGM cells generate
adherent colonies in CFU-assays similar to
CD34
+/c-Kit
low cells
The level of c-Kit expression was an indicator of the
differentiation potential of 10Æ5 dpc CD34
+ AGM cells
(Fig 1B). In methylcellulose assays, isolated CD34
+/c-Kit
high
cells generated haematopoietic colonies typical of committed
progenitors. To assess the effect of BMP4 on the colony-
forming potential of committed progenitors, colonies
generated in 10- or 20-d cultures from FACS-isolated
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Fig 2. Bone morphogenetic protein 4 (BMP4) increases the plating efﬁciency (growth/survival) of mid-gestation aorta-gonad-mesonephros (AGM)-
derived CD34
+/c-Kit
high cells in 10-d culture. (A) Addition of BMP4 (open symbols) results in an increase in the number of colonies produced at
10Æ5 dpc compared with serum-free conditions ()BMP4, solid symbols). Statistical analyses were performed using the Kruskal–Wallis test (different
embryonic ages) and the non-parametric Wilcoxon signed rank test to compare the collective results for a given embryonic age with and without
addition of BMP4. Results were found to be signiﬁcant at 10Æ5 dpc (P <0 Æ001) but not signiﬁcant at 9Æ5 dpc or 11Æ5 dpc (P ¼ 0Æ068 and P ¼ 0Æ595
respectively). (B) The effect of BMP4 was consistent at 10Æ5 dpc, increasing plating efﬁciency/CFUs by 50% or greater in 12 out of 19 separate
experiments. BMP inhibitors. (C) soluble BMP type I-receptor (200 ng/ml) and (D) Noggin (200 ng/ml) neutralize the effect of BMP4 on cultured
CD34
+/c-Kit
high cells (10Æ5 dpc).
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+/c-kit
high cells were plated into methylcellulose contain-
ing a combination of haematopoietic cytokines for 2–3 weeks.
The small number of cells per colony allowed very low density
distribution in methylcellulose, however, the exact number of
cells plated could not be accurately counted therefore quan-
titative comparison was not attempted.
CD34
+/c-Kit
high AGM cells cultured for 10 d or more in
serum-free medium alone or with BMP4 retained the capacity
to generate granulocyte/monocyte colonies across all
embryonic ages tested (Table I, Fig 3A), suggesting that
lineage-restricted haematopoietic progenitors (CFU-GM) were
maintained or generated within the cultures. BMP4-treated
CD34
+/c-Kit
high cells also generated colonies that contained
erythroid cells, indicating the presence of more primitive, less
restricted progenitors (CFU-GEMM) (Fig 3B).
Most strikingly, CD34
+/c-kit
high cells at all embryonic ages
pre-cultured with BMP4 generated adherent colonies that
closely resembled the colonies produced from CD34
+/c-Kit
low
cells at day 0 (Table I, Fig 3C). These colonies contained
a mixture of adherent spindle-shaped and large round cells
overlaid by clusters of smaller round cells and frequently
formed extensive networks that persisted in culture for more
than 4 weeks. Immunocytochemical analysis of adherent
colonies showed expression of the stromal molecule STRO1
in large round cells, endothelial (Flk1, endoglin) markers in
large round and spindle cells and the haematopoietic marker
CD45 in small round cells. Adherent colonies therefore
appeared to comprise a combination of stromal, endothelial
and haematopoietic cells. In most cultures, both non-adherent
haematopoietic and adherent colonies were generated, how-
ever, a number of cultures produced adherent colonies
exclusively. This adherent colony-forming potential was
retained by cells isolated at 10Æ5 dpc but lost on extended
culture of 11Æ5 dpc cells. Importantly, no adherent colonies
were generated from CD34
+/c-kit
high cultured in the absence
of exogenous BMP4. The colony-forming potential of
AGM-derived CD34
+/c-Kit
high cells (10Æ5 dpc) that had been
Table I. Morphology of colonies derived from CD34
+/c-Kit
high aorta-
gonad-mesonephros (AGM) cells pre-cultured )/+ bone morphoge-
netic protein 4 (BMP4) at different embryonic ages. Numbers are
expressed as the percentage of AGM-derived colony-forming units/
primary colonies that produced non-adherent haematopoietic and/or
adherent colonies in secondary methylcellulose culture. Adherent
colonies contained a combination of three morphologically distinct cell
types. Only cells pre-cultured with BMP4 produced polymorphic
colonies.
Age
(dpc)
Time in
culture (d)
Haematopoietic
colonies (%)
Adherent
colonies (%)
n ± BMP4 )BMP4 +BMP4 )BMP4 +BMP4
9Æ5 10 100 88 0 70 7/17
10Æ5 10 50 83 0 66 22/30
20 63 81 0 81 11/11
11Æ5 10 70 64 0 36 10/11
20 0 30 0 0 1/10
n, number of primary colonies )/+ BMP4 plated in methylcellulose;
dpc, days post-coitum.
(A) 
(B)
(C)
Fig 3. CD34
+/c-Kit
high aorta-gonad-mesonephros (AGM) cells cul-
tured with bone morphogenetic protein 4 (BMP4) generate adherent
colonies resembling CD34
+/c-Kit
low colonies. (A) CD34
+/c-Kit
high cells
isolated by FACS from AGM tissue (10Æ5 dpc) and cultured for 10 d in
serum-free medium alone ()BMP4) generate haematopoietic colonies
composed of granulocytic/myeloid cells (CFU-GM). BMP4-treated
CD34
+/c-Kit
high cells also produce (B) haematopoietic colonies which
also contain erythroid cells (CFU-GEMM) and (C) at a similar fre-
quency, adherent colonies which resemble colonies generated from
freshly isolated CD34
+/c-Kit
low cells of the same embryonic age.
Adherent colonies contain three morphologically distinct cell types:
phase-dim spindle-shaped cells (arrowhead), large round cells (arrow)
and phase-bright small, round cells (hatched arrow).
C. J. Marshall et al
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nation with BMP4 was also assessed (Table II). The addition of
noggin prevented polymorphic colony formation although
some hematopoietic (CFU-GM) colonies did develop. Soluble
BMP-receptor completely blocked colony formation.
Discussion
Stem cells play an essential role in the generation (embryonic/
foetal) and regeneration (adult) of tissues. To fulﬁl these roles,
stem cells must survive and persist within tissues and also be
able to generate specialized, differentiated progeny as required.
Maintenance of the stem cell pool therefore requires a precise
balance between a number of processes: self-renewal (quies-
cence), proliferation, differentiation and apoptosis. These
processes are regulated by a complex network of environmen-
tal (niche) signals linked to intrinsic pathways that can have
either a permissive or an inhibitory effect on stem cell
behaviour. BMP is an example of an extracellular molecule that
functions in this way, with distinct or overlapping functions
that induce or inhibit, depending on the stem cell system and
speciﬁcity of receptor binding (Zhang & Li, 2005).
The mammalian AGM region contains a niche in which
haematopoietic stem cells are generated from a pre-haemat-
opoietic cell during embryogenesis and BMP4 is expressed
during this period of HSC emergence in vivo in human
embryos (Marshall et al, 2000). The AGM is possibly the only
intraembryonic site of multipotent HSC speciﬁcation during
development, with subsequent foetal liver and bone marrow
haematopoiesis seeded by the self-renewal and proliferation of
AGM-derived cells rather than the de novo generation of HSCs
in these tissues. The AGM therefore provides an important and
possibly unique environment for the study of early haemat-
opoietic ontogeny in terms of cellular origin and molecular
regulation.
The most primitive haematopoietic progenitors in human
bone marrow express the stem cell factor receptor c-Kit at low
levels compared to more committed progenitors (Gunji et al,
1993; Katayama et al, 1993; Doi et al, 1997; Lian et al, 1997).
This study showed that c-Kit expression in murine embryonic
CD34
+ AGM cells also distinguishes two subpopulations that
differ in colony-forming potential. The c-Kit
high compartment
expressed the pan-leucocyte marker CD45 and contained
lineage-restricted haematopoietic progenitors (CFU-GM). In
contrast, the CD34
+/c-Kit
low subpopulation was CD45-nega-
tive and did not contain CFU-GM but generated adherent
colonies containing multiple cell types.
CD34
+/c-Kit
low AGM cells also express the vascular endo-
thelial growth factor (VEGF) receptor Flk1. Flk1 is expressed
on cell blast-colony forming cells (BL-CFCs) derived from
murine ES cells in culture (Faloon et al, 2000). These BL-CFCs
display both endothelial and haematopoietic potential and are
thought to represent the in vitro equivalent of the haeman-
gioblast (Choi et al, 1998). Flk1 expression is lost in BL-CFC-
derived cells that commit to haematopoiesis. In agreement
with this, AGM-derived CD34
+/c-Kit
high cells were haemat-
opoietic and Flk1
neg.
When CD34
+/c-Kit+ cells were cultured with BMP4, the
number of c-Kit
low cells rapidly increased. Tracking of c-Kit
expression in ex vivo culture suggests that the receptor was
down-modulated in CD34
+/c-Kit
high cells (10Æ5 dpc) within
48 h (data not shown). However, the small numbers of
c-Kit
high cells did not account for the comparatively large
increase in the number of c-Kit
low cells. Instead, expansion of
the CD34
+/c-Kit
low pool appeared to result from a combina-
tion of cell division in both high and low compartments
coupled with down modulation of c-Kit receptor expression in
c-Kit
high cells (data not shown). Consistent with this, in
longer-term culture with BMP4, CD34
+/c-Kit
high cells had
increased growth/survival and acquired similar differentiation
potential to c-Kit
low cells in CFU assays. This effect was BMP
speciﬁc and could be blocked by BMP antagonists. Compar-
ison of different mid-gestation embryonic ages also suggested
that this capacity was most evident in cells isolated from
10Æ5 dpc murine embryos, corresponding to the height of
AGM haematopoietic activity in vivo.
Adherent colonies generated from freshly isolated CD34
+/
c-Kit
low and BMP4-treated CD34
+/c-Kit
high cells contained
multiple cell types and could persist and expand in culture for
several weeks. Preliminary analysis of these colonies suggested
that they contained a mixture of cells that express stromal,
endothelial or haematopoietic markers (data not shown). They
also morphologically resembled haemangioblast colonies
obtained from human embryonic stem cells cultured with
BMP4 (Kennedy et al, 2007).
In the presence of BMP4, therefore, CD34/c-Kit AGM cells
underwent a change in differentiation potential coincident
with a change in c-Kit expression. This concurs with the in vivo
expression pattern of c-Kit within the embryonic AGM. In the
human embryo, KIT mRNA is expressed at higher levels in
cells within intraaortic CD45
+ haematopoietic clusters com-
pared to the surrounding vasculature (Labastie et al, 1998).
AGM-derived c-Kit
high cells may therefore correspond to cells
within intraaortic haematopoietic clusters in the mid-gestation
murine AGM. Similarly, in vivo CD34 expression patterns in
mouse and human embryos suggest that CD34
+/c-Kit
low cells
are located within the vascular walls including the dorsal aorta
(Tavian et al, 1996; Wood et al, 1997). CD34
+/c-Kit
low cells
Table II. BMP inhibitors block formation of adherent colonies from
CD34
+/c-Kit
high AGM cells (10Æ5 dpc) pre-cultured + BMP4.
Haematopoietic
colonies (%)
Adherent
colonies (%) n
)BMP4 64 0 11
+BMP4 68 27 22
+BMP4 + soluble BMPR 0 0 5
+BMP4 + noggin 50 0 6
n, number of primary colonies plated in methylcellulose.
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between endothelial and haematopoietic cells.
Our ﬁndings regarding the regulation of c-Kit expression
during AGM haematopoiesis agree with and add to a recent
study in which E11.5 AGM cells were cultured for a few days
with fetal calf serum (FCS), SCF, basic ﬁbroblast growth factor
(bFGF) and oncostatin M (Nobuhisa et al, 2007). Three
populations of cells were identiﬁed based on levels of CD45/
c-Kit expression: CD45
low/c-Kit+ with haematopoietic CFU
activity, CD45
low/c-Kit
neg granulocytes and CD45
high/c-Kit
low/
neg macrophages. In subsequent co-culture with fresh AGM
cells, only CD45
low/c-Kit+ cells had the capacity to reproduce,
differentiate into CD45
low/c-Kit
neg granulocytes and CD45
high/
c-Kit
low/neg macrophages and repopulate irradiated recipients,
suggesting that they include HSCs. It was also observed that
bFGF and oncostatin M were not required and insufﬁcient to
maintain the CD45
low/c-Kit+ population in culture. The
present study further subdivided the c-Kit+ AGM population
and cultured these cells in the absence of FCS. BMP4
speciﬁcally was able to maintain the more primitive CD34
+/
c-Kit
low/CD45
low/neg population. Collectively, these observa-
tions suggest that c-Kit expression during HSC development
proceeds from low to high but is lost in committed haemat-
opoietic progenitors.
Based on these results, we propose a model for mammalian
embryonic haematopoietic development that requires BMP
signalling at an early stage for maintenance of multipotent cells
in the AGM. BMP4 maintains and possibly activates progen-
itors or stem cells within the ventral ﬂoor of the endothelium
lining the dorsal aorta. At this point, these cells have the
potential to self-renew or to differentiate along one of at least
two lineage pathways. In response to BMP4 and/or other
factors within the AGM niche, these progenitors proliferate
and are pushed outwards from the vessel wall to form clusters
in the lumen. These clusters are continuous with and
connected to the vessel wall by cell–cell junctions (Marshall
& Thrasher, 2001). As cells within the developing clusters
move away from the aortic wall and the source of BMP, they
lose multipotency and become committed to a haematopoietic
fate. Exposure of lineage-committed progenitors to BMP4
in vitro restores a more primitive phenotype, suggesting that
BMP4 maintains precursors or HSCs within the AGM, partly
by blocking further haematopoietic differentiation. In the
embryonic AGM, therefore, BMP4 may have a similar effect on
cell behaviour to that of TGFb on postnatal cells in the
maintenance of a primitive, multipotent population that
resides within the CD34
+/c-Kit
low compartment.
This model for BMP function is supported by studies on the
drosophila ovariole in which BMP signals produced from niche
cells maintain self-renewing germline stem cells by blocking
differentiation (Kai & Spradling, 2004; Song et al, 2004).
Short-range BMP-signalling induces elevated levels of a group
of proteins in stem cells adjacent to cap cells at the niche
interface. These proteins bind to the silencer element of a dif-
ferentiation-promoting gene bag of marbles (bam) repressing
its transcription and blocking differentiation to the next stage
of germ cell development. As cells move away from the cap
cells and beyond BMP signalling range, bam is expressed and
the cells can differentiate. BMP also expands the BL-CFC
haemangioblast population and consequently increases hae-
matopoietic output in murine ES cells (Zafonte et al, 2007).
Members of the Runx family of transcription factors have
also been linked to the BMP pathway. Runx1 is transiently
expressed in the ﬂoor of the dorsal aorta during the period of
haematopoietic activity and is required for HSC generation
(North et al, 1999). Recently it has been demonstrated that the
BMP4/Smad signalling pathway, the SCL/Tal1 transcription
network and regulation of Runx1 activity are linked and
determine HSC development (Pimanda et al, 2007). Within
the embryonic AGM, BMP-activated Smad-Runx complexes
may regulate expression of target genes involved in lineage
commitment and haematopoietic speciﬁcation.
The development of more reliable and efﬁcient culture
systems for clinical applications requires a greater knowledge
of how stem cells are regulated at the molecular level. The
microenvironment that supports mammalian HSC generation
in vivo contains a variety of factors that may work synergis-
tically or antagonistically at different stages of HSC induction,
maintenance and maturation. Within the embryonic context,
we have placed BMP4 within this complex network at an early
stage, possibly in the regulation of haemangioblast develop-
ment, resulting in the production of a pool HSCs to seed the
adult haematopoietic system. Further investigations will reveal
how growth factors co-operate to regulate haematopoietic
development from embryo to adult and so unravel the
complicated pathway that leads from mesodermal cell to
blood.
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